发明名称 Use of dynamin ring stabilizers
摘要 There is provided a method for promoting dynamin ring formation and/or maintenance of dynamin rings in a cell, comprising treating the cell with an effective amount of a dynamin ring stabilizer, or a prodrug or pharmaceutically acceptable salt of the dynamin ring stabilizer. The maintenance or accumulation of dynamin ring formation has particular application in the prophylaxis or treatment of a kidney disease or condition characterized by proteinuria. A dynamin ring stabilizer can be any agent that interacts with dynamin to promote dynamin ring assembly and/or inhibit dynamin ring disassembly. There are also provided methods for prophylaxis or treatment of podocyte dysfunction and/or maintaining or inducing actin cytoskeleton formation in a cell utilizing dynamin ring stabilizers, and for screening a test agent for use as a dynamin ring stabilizer.
申请公布号 US8809386(B2) 申请公布日期 2014.08.19
申请号 US201013321415 申请日期 2010.05.21
申请人 Children's Medical Research Institute;The General Hospital Corporation 发明人 Robinson Phillip J.;Sever Sanja
分类号 A61K31/35 主分类号 A61K31/35
代理机构 Rothwell, Figg, Ernst & Manbeck P.C. 代理人 Rothwell, Figg, Ernst & Manbeck P.C.
主权项 1. A method for prophylaxis or treatment of a kidney disease or condition characterized by proteinuria, comprising administering to an individual in need thereof an effective amount of at least one dynamin ring stabilizer for maintaining and/or inducing actin cytoskeleton formation, or prodrug or pharmaceutically acceptable salt of the dynamin ring stabilizer.
地址 Westmead, NSW AU